TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Changes in dietary protein intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in clinical characteristics of PKC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perioperative data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Toxicities including on sexual function
Endpoint domain: Adverse events/effects
Primary endpoint: Change in proinflammatory miRNAs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of patients with no fluid on OCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective shoulder function (Constant score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of brain structural and functional changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of Constant Murley Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Auditory Hallucinations Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Toxicity based upon adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Response Evaluation Criteria in Solid Tumors (RESIST)
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma AX AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Infants Who Test Positive for Fecal Rotavirus Vaccine-strain Virus Shedding Post-vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Infants With Rotavirus-specific Plasma Immunoglobulin A (IgA) Seroconversion Post-vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Infants With Successful Vaccine Take
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Seroprotected Subjects for Anti-diphtheria and Anti-tetanus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antibody Concentrations Against Pertussis Toxoid, Filamentous Hemagglutinin, and Pertactin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Validity of the italian version of the PRO-CTCAE
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Responsiveness of the italian version of the PRO-CTCAE
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Instability of distal radioulnar joint (pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Instability of distal radioulnar joint (displacement)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Occurrence of objective clinical manifestations of Lyme borreliosis and post-Lyme symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nighttime self-regulated sleep duration
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Muscle mass (grams)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of study participants achieving 80% or higher engagement score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Unified Parkinson's Disease Rating Scale (UPDRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Progressive Supranuclear Palsy Rating Scale (PSPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in Foveal Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Macular Fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertebral fracture detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Postoperative length of hospital stays
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Breast feeding initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Clinical Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Organ Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Partial pressure of arterial blood carbon dioxide (PaCO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Clinically Significant Exacerbations of Asthma Per Year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Positive and negative symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pain-free walking time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in amniotic fluid index (AFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Quality and quantity of sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Neurobehavioral performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Pain profile scale parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Vasopressor Independence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Sequential Organ Failure Assessment (SOFA) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) based on dose-limiting toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Time of PSA Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: G6PD enzymatic activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuroendocrine stress hormones in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Neuroendocrine stress hormones in follicular fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of patients with confirmed Diabetic Retinopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Breast cancer relapse
Endpoint domain: Mortality/survival
Primary endpoint: Days free of vasopressors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in physical activity participation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measures of body composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Maximum voluntary contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Reaction Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in wolf motor function test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Probing Depth change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported sedentary
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Participants With PAH Who Experienced Severe Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With PAH Who Experienced AEs of Moderate Severity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With PAH Who Experienced AEs of Mild Severity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Gout Flares Per Participant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Keratomic corneal astigmatism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in Chest compression depth (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Chest compression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl Myer Upper Limb Motor Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Small Bowel Transit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total Erythrocyte Aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence rate of progression of disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Genioglossus Activity During NREM Sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of peri-apical bone healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: A/E monitoring
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic relevance of laser confocal microscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Suppression of Serum Testosterone to Castrate Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Clinical Remission of systemic infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in allergen concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients Who Experienced at Least One Adverse Event(s)
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline to End of Treatment for Leucocytes Count in Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change From Baseline to End of Treatment for Systolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Independence of haemodialysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Days from start to independent oral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum b-cryptoxanthin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain duration after treatment termination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spent treatment fee after agreement with car insurance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement of anxiety and depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Uptake of evidence-based diabetes prevention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of time location strategies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Unsupported Upper Limb Exercise Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dental and soft tissue position assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attack Rate of Shigellosis
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Salivary Flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood levels of biomarkers of cardiac damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: blood levels of biomarkers of hemodynamic impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: blood levels of biomarkers of cardiac fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Montgomery-Ǻsberg Depression Rating Scale (MADRS) total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prediction of antibody-mediated rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Live birth infant rate
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of eligible HEI receiving POC EID testing at birth
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: PPT of the knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: volumetric uptake values of 18-FDGal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effects on temporomandibular joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effects on orofacial muscular complex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Developing a second primary malignancy (SPM)
Endpoint domain: Mortality/survival
Primary endpoint: Annual relapse rate (ARR) of NMOSD Attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline Ulcer Healing Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3 Month Ulcer Healing Rate Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6 Month Ulcer Healing Rate Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of Grade II-IV Acute Graft Versus Host Disease (GVHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: number of patients who avoided endotracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Gene expression profiling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Stopping or reducing rate of antianginal drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Completion rate of thoracoscopic esophagectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Quality of life impact due to pruritus
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: GMT and frequency of 4-fold or greater increases in serum HAI antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of subjects achieving a serum hemagglutination inhibition (HAI) antibody titer of >= 1:40
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse event (AE) or serious adverse event (SAE) information
Endpoint domain: Adverse events/effects
Primary endpoint: Insulin Secretion Rate (ISR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: dynamic uptake and washout of [18F] CFPyPB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of hemodynamic parameter MAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of hemodynamic parameters HR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of blood SPO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematological findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in mean of radiographic interproximal bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rating of image quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptomatic skeletal event (SSE)-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Elimination of MRSA colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of subjects achieving target HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of subjects achieving target LDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Venous thrombotic event (VTE) or arterial thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: students' mean Scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Panic Disorder Severity Scale (PDSS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of renal or hepatic dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Composite of efficacy markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With No CSF Leak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rapid Disease Progression
Endpoint domain: Mortality/survival
Primary endpoint: Thromboelastograph values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: BMS-914392 plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physicians global assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Direct costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Preference values
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma levels of inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Urinary biomarkers of oxidative stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High sensibility troponins T blood level variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Functional Walking Capacity (6 Minute walk test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of CRC risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance Indicators of Fecal Immunochemical Test (FIT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Performance Indicators of Colonoscopic Examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Anti-clotting effect of flavonoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Diabetes Empowerment Scale (DES) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diabetes Management Self-Efficacy Scale (DMSES) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dose Limiting Toxicities (DLT) incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Abscopal effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients alive without progression at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants with Ovarian Insufficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Prevalence of unrecognized obesity-related diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intentions To Have Sexual Intercourse
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intentions to Use Condoms and Contraceptives
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to Kidney Transplantation
Endpoint domain: Mortality/survival
Primary endpoint: Discrimination of benign and malignant gynecologic disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Progression-free rate at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short Form-36 Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Vitamin D deficiency percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of subjects with esophageal reflux during night-time arousals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Risk for adverse medical conditions
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of adverse device effects
Endpoint domain: Adverse events/effects
Primary endpoint: Rabies Neutralizing Antibody Titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: awake episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative Skin Entrance Radiation Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Response (Pain Relief)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean area under the curve plasma HIV RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of leukemia cells in ovarian cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of leukemia cells expressed in function of total cell number living
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change From Baseline in Platelet Counts on Day 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Presence of brown adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of Rise of Serum PSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incremental area under the curve for insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Post-prandial glycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes